EACVI survey on the use of multi-modality cardiovascular imaging in immune-mediated inflammatory diseases

Clicks: 3
ID: 313344
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #23 of 48 articles by views in European Heart Journal - Imaging Methods and Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aim To scope the current European landscape of multi-modality cardiovascular imaging practices in Immune-Mediated Inflammatory Diseases (IMIDs). Methods & Results An electronic (e)-survey was distributed to members of the European Association of Cardiovascular Imaging (EACVI) about imaging in cardio-rheumatology. A parallel e-survey focused on the use of coronary CT for cardiovascular disease (CVD) risk-stratification in IMIDs was conducted via the British Society of Cardiovascular Imaging (BSCI). Of the total 111 respondents to the EACVI survey, 92 (82.9%) were consultant-grade physicians and 68 (61.3%) worked in tertiary centres. These individuals had varied experience in cardio-rheumatology, with limited access to dedicated cardio-rheumatology services and training opportunities. Sixty-nine (62.2%) used coronary CT to guide preventive therapies in IMID patients with borderline risk scores and cardiac symptoms, with a preference for coronary CT angiography over coronary artery calcium scoring alone in this setting. These findings about coronary CT were corroborated in the parallel survey of 54 BSCI members. When using CMR to detect myocardial involvement in IMIDs, 73/111 (67.6%) perceived a need for IMID-specific CMR criteria beyond the current modified Lake Louise criteria for myocarditis. In terms of nuclear imaging, timely access to 18F-fluorodeoxyglucose PET imaging was identified as a barrier for diagnosing large-vessel vasculitis, and 61/111 (57%) of responders felt that the development of novel radionuclide tracers should be a future research priority. Conclusion This European survey highlights the need for dedicated cardio-rheumatology services and specialist training, and further evidence to inform future clinical practice recommendations on multi-modality cardiovascular imaging in IMIDs.
Reference Key
openalex_W7161394274 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Marta Peverelli, Beth Whittington, Theo Pezel, Tor Biering-Sørensen, Simona Botezatu, Robert Manka, Sanjeev Bhattacharyya, J F Rodriguez Palomares, Ahmet Demirkıran, Maria Lembo, Jonathan Weir-McCall, Timothy Fairbairn, Michelle C Williams, TARYN YOUNGSTEIN, Ziad Mallat, Declan P. O’Regan, Maya H Buch, Vanessa Ferreira, Sven Plein, Anna Baritussio, M Dweck, Jason M. Tarkin
Journal European Heart Journal - Imaging Methods and Practice
Year 2026
DOI
10.1093/ehjimp/qyag094
URL
https://doi.org/10.1093/ehjimp/qyag094
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.